New Resource for Accelerated Medical Device Development
NAGLREITER™ was built on joining forces and attacking opportunities that result in exceptional medical designs and cost-effective solutions. Collaborating with NAMSA® expands our full service offering and furthers our ability to successfully bring a medical device idea to life. Click the link below for an overview of our partnership and the services we provide.
NAGLREITER and NAMSA: The Ideal Development Team


Meet with NAGLREITER® MDDO at DeviceTalks Boston – October 9th-10th, 2018
Naglreiter is proud to be a gold sponsor at the DeviceTalks event in Boston. This years’ experience will feature three tracks filled with expertly curated content created by our industry for our industry. The ECO-SYSTEM track will focus on issues confronting med-tech companies across Boston and beyond; the TECHNOLOGY track will drill down into the hottest new tech that’s changing med-tech. And the INVESTMENT track will highlight issues for emerging med-tech companies seeking investment for growth.

We invite you to stop by booth #615 to meet with Naglreiter MDDO and NAMSA for networking opportunities. We look forward to seeing you there!


NAMSA Start-Up Summit – October 3rd, 2018
Just getting started in medical device development? Join us at NAMSA’s complimentary summit in Houston where we’ll spend half a day discussing product design and development, clinical research, guidance for the industry, and much more!
Learn More | Register Now!


2018 Summer Internship Completed – July 27th, 2018
Congratulations to all of our NMDDO Summer Interns! Today marked the completion of their 9 week summer internship program. Our company values and encourages the contributions and development of students. It is a good way to cultivate talent for our future team. We were pleased to have them as part of our team.


Naglreiter has recently received its ISO 13485:2016 Quality Management System Certification for the following scope:
Design, Development, Manufacture and Distribution of implantable and non-implantable cardiovascular devices.
The full Quality Management System audit was completed in May of this year and the certification was received and is effective as of July 5th 2018.


NAGLREITER® MDDO sponsors the 15th Annual SNIS Meeting in San Francisco California. July 23- 26, 2018
Naglreiter is a proud sponsor for this year’s Society of NeuroInterventional Surgery conference taking place in San Francisco California. There will be multiple sessions which span the full spectrum of neurointervention to a strong slate of abstracts that reflect the shared vision for research. We invite you to join us at the Exhibitor’s Hall at our booth #605. We look forward to seeing you there.


NAGLREITER® MDDO becomes a Gold Sponsor at the 18th Annual New York City Venture Summit. July 10th – 11th 2018.
Naglreiter was proud to be a sponsor at this year’s New York City Venture Summit, an exclusive investment conference uniting venture capital and innovation. More than 100 Venture Capitalists from leading VC funds speak each year at the annual New York Venture Summit. The Summit attracts senior level executives (CEOs, Presidents, VPs, COOs, CFOs, and Managing Partners) of venture capital firms, investment banks, early stage and emerging growth companies from a variety of industries including: Software, IT, Wireless, Internet, Clean-tech, Life Sciences, Biotech, Healthcare, Investment and venture capital.


2018 Summer Internship – May 30, 2018
Naglreiter has officially kicked off its 2018 Summer Internship Program. This year we have three students who have joined our team. We at Naglreiter know internships give students the opportunity to gain valuable applied experience and make connections in professional fields. As employers, it gives us the opportunity to cultivate talent. We are pleased to have them join our team.


May 8, 2018
NAMSA and Naglreiter partner to provide Innovative Development Solution to Global Medical Device Manufacturers.

Read Press Release


NAMSA Start-Up Summit – April 25, 2018
Boston, MA: It is not uncommon for early-stage medical device companies, often with few resources, to find it challenging to stay abreast of the requirements needed for successful product development and market introduction. NAMSA, in partnership with Naglreiter, will provide a unique half-day event for young device firms to learn about: 1) “The Product Development Process;” and 2) “FDA Trends & Guidance for Industry.”

Learn More / Register Now!


NAMSA’s Start-Up Summit – March 21, 2018
Are you an early stage medical device organization in the Twin Cities area? Join NAMSA for our complimentary Start-Up Summit! NAMSA, in partnership with Naglreiter, will provide a unique half-day event for young device firms to learn about the product development process and FDA trends and guidance. Our experienced teams will share best practices and real-world lessons learned to help guide you on your path to successful product development.

Learn More / Register Now!


November 9, 2017
Not all medical device incubators are the same. Brett Naglreiter offers several questions that will help to ensure you are choosing the right firm to enable you and your product to succeed.

Read White Paper


October 16, 2017
NAGLREITER® Medical Device Development Organization uses a novel approach to shorten the timeline between medical device concept and device submission.

Read Article


August 30, 2017
NAGLREITER® MDDO client receives U.S. FDA 510(k) clearance for the Hourglass™ Peripheral Embolisation Plug.

Read Press Release


August 21, 2017
Brett Naglreiter shares his perspective on why you might consider partnering with a Medical Device Development Organization versus managing device development on your own.

Read White Paper



April 21, 2017
Brett Naglreiter shares his point of view on medtech startups with Medical Design & Outsourcing.

Read Article